Reta glucagon-like peptide-1 (GLP-1) receptor agonists provide a groundbreaking method to diabetes management. These innovative therapies work by mimicking the physiological actions of GLP-1, a hormone released by the https://matteoelgb714877.azzablog.com/39391832/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes